Health technology company Seqster announced Thursday the launch of its new 1-Click Sites platform, tapping BioIVT as its first deployment partner.
The tool allows clinical sites to share patient-consented electronic health record (EHR) data with clinical trial sponsors. Each site or network using the platform receives its own FDA 21 CFR Part 11-compliant study portal, with Seqster managing data aggregation, automated eligibility screening and continuous monitoring. Organizations' sites can use the platform as full research locations or strategic referral centers, according to the announcement.
The launch “eliminates the barriers” for systems trying to get involved with clinical research, Ardy Arianpour, Seqster CEO and co-founder, told Fierce Healthcare in an interview.
“Clinical research really depends on understanding the whole patient journey,” Arianpour said. “The traditional sites enablement approach required months of IT setup, custom EHR integrations on the interoperability side, … contracts and significant capital investment. We have completely cut that with our platform.”
Arianpour said the company's better results are not just based on how fast it can bring longitudinal health data, but how quickly it can “launch an end-to-end solution” to turn clinical sites into “research-ready data collection points.”
The 1-Click Sites platform allows organizations to access data sharing “in a matter of days,” according to the announcement.
“We are connecting the dots of not just data, but we're connecting the dots of the patient, plus the recruitment and the site activation in a way that is seamless for both the researchers and for the patients,” Arianpour said.
Upon scaling the platform at BioIVT, Arianpour said one of the goals of the partnership is to utilize data for drug discovery and development. “We have a fuller picture on the patient when we have their bio specimen data,” Arianpour said.
BioIVT Vice President of Corporate Development Jake Maxwell said in the announcement that the technology allows better tracking of lab results and outcomes throughout the treatment spectrum to “deliver deeper insights into how therapies perform in the real world.”
"Together with SEQSTER, we look forward to empowering drug development with more complete, connected patient data that drives better, more informed decisions,” Maxwell said.
Launched in 2016, the health tech startup develops tools to access longitudinal and comprehensive healthcare data in real time, both at a patient level and at scale. This includes EHRs, pharmacy data, lab data, genomic data (DNA), fitness wearables data and social determinants of health (SDOH) information.
“The whole premise was putting the patient at the center of healthcare,” Arianpour said.
In March, Seqster also launched its 1-Click DataLake, a real-world data platform aimed at accelerating study design, recruitment and evidence generation. It includes data from more than 150 million de-identified patients and 200,000 clinicians across the U.S.
Arianpour said the launch of 1-Click Sites completes the company’s “five core products” for healthcare and life sciences.
“That's what's really exciting,” Arianpour said. “And [the products] all work off one another, because you have to be able to pull the data in order to deploy a platform for 1-Click Sites. And if we didn't build these specific tools to standardize and harmonize data on the back end, then there's no way that this would be possible with such a premier company in the space.”